Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Age Ageing. 2021 Nov 10;50(6):2157-2166. doi: 10.1093/ageing/afab149.
Multicomponent interventions improve physical function and frailty in older adults, but their long-term benefit remains uncertain.
This prospective non-randomised study was conducted in 383 older Koreans (mean age, 76.8 years; female 72.3%) who were living alone or receiving medical aid. Of these, 187 individuals chose to receive a 24-week intervention that consisted of group exercise, nutritional supplements, depression management, deprescribing and home hazard reduction. The remaining 196 individuals received usual care. We compared the short physical performance battery (SPPB) score (0-12 points), frailty phenotype scale (0-5 points) and deficit-accumulation frailty index (0-1) at baseline, 6, 18 and 30 months.
After 1:1 propensity score matching (n = 117 per group), the mean SPPB scores for the intervention and comparison groups were 7.6 versus 7.6 at baseline, 10.7 versus 7.1 at 6 months (mean difference, 3.5; 95% confidence interval [CI], 2.8-4.2), 9.1 versus 7.8 at 18 months (1.3; 95% CI, 0.6-2.0) and 8.6 versus 7.5 at 30 months (1.1; 95% CI, 0.4-1.8). The intervention group had lower frailty phenotype scale (1.1 versus 1.8; difference, -0.7; 95% CI -1.0 to -0.3) and frailty index (0.22 versus 0.27; difference, -0.04; -0.06 to -0.02) at 6 months, but similar scores at 18 and 30 months. The 30-month mean institutionalisation-free survival time was 28.5 months in the intervention group versus 23.3 months in the comparison group (difference, 5.2 months; 95% CI, 3.1-7.4).
The 24-week multicomponent intervention showed sustained improvement in physical function, temporary reduction in frailty and longer institutionalisation-free survival over 30 months.
多组分干预措施可改善老年人的身体功能和虚弱状况,但长期效果仍不确定。
本前瞻性非随机研究纳入 383 名独居或接受医疗救助的韩国老年人(平均年龄 76.8 岁;女性占 72.3%)。其中 187 人选择接受为期 24 周的干预,包括小组运动、营养补充、抑郁管理、撤药和家庭危险减少。其余 196 人接受常规护理。我们比较了基线、6、18 和 30 个月时的短体表现电池(SPPB)评分(0-12 分)、虚弱表型量表(0-5 分)和缺陷累积虚弱指数(0-1)。
经过 1:1 倾向评分匹配(每组 n=117),干预组和对照组的 SPPB 评分分别为:基线时 7.6 分比 7.6 分,6 个月时 10.7 分比 7.1 分(平均差异 3.5;95%置信区间 [CI],2.8-4.2),18 个月时 9.1 分比 7.8 分(1.3;95% CI,0.6-2.0),30 个月时 8.6 分比 7.5 分(1.1;95% CI,0.4-1.8)。干预组在 6 个月时的虚弱表型量表(1.1 比 1.8;差值,-0.7;95%CI -1.0 至 -0.3)和虚弱指数(0.22 比 0.27;差值,-0.04;-0.06 至 -0.02)较低,但在 18 和 30 个月时的评分相似。干预组 30 个月的无机构化生存时间的平均为 28.5 个月,对照组为 23.3 个月(差值,5.2 个月;95%CI,3.1-7.4)。
24 周多组分干预措施可在 30 个月内持续改善身体功能,暂时减轻虚弱程度,并延长无机构化生存时间。